Daniel Joseph OConnell insider trades
Open-market stock purchases and sales by Daniel Joseph OConnell, Chief Executive Officer at Acumen Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 6, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 22, 2026 | ABOS Acumen Pharmaceuticals, Inc | Sold | $5.1K |
| Jan 21, 2026 | ABOS Acumen Pharmaceuticals, Inc | Sold | $16.9K |
| Jan 20, 2026 | ABOS Acumen Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 20, 2026 | ABOS Acumen Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 12, 2026 | ABOS Acumen Pharmaceuticals, Inc | Sold | $9.3K |
| Jan 9, 2026 | ABOS Acumen Pharmaceuticals, Inc | Sold | $22.8K |
| Jan 8, 2026 | ABOS Acumen Pharmaceuticals, Inc | Sold | $14.8K |
| Jan 7, 2026 | ABOS Acumen Pharmaceuticals, Inc | Sold | $75K |
| Jan 6, 2026 | ABOS Acumen Pharmaceuticals, Inc | Sold | $10K |
| Jan 5, 2026 | ABOS Acumen Pharmaceuticals, Inc | Sold | $9.2K |
Companies traded
- ABOS Acumen Pharmaceuticals, Inc: 11 sales, last Jan 22, 2026
Get free alerts when Daniel Joseph OConnell files a new trade →